Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 66 were in positive territory over the last fortnight, 18 were flat and 47 saw their share prices fall.

Code Name Price $ (May 27) 2 week return % 1 year return % Market cap
IPD IMPEDIMED LTD 0.08 107 -52 $85,144,264
ATX AMPLIA THERAPEUTICS LTD 0.14 63 17 $9,304,846
ANP ANTISENSE THERAPEUTICS LTD 0.073 61 45 $36,170,112
OSP OSPREY MEDICAL INC-CDI 0.018 60 -86 $20,568,652
RCE RECCE PHARMACEUTICALS LTD 0.735 60 245 $103,414,560
1AD ADALTA LTD 0.087 42 -61 $13,935,377
LBT LBT INNOVATIONS LTD 0.16 39 -18 $37,686,364
VBS VECTUS BIOSYSTEMS LTD 0.68 39 64 $16,085,275
IBX IMAGION BIOSYSTEMS LTD 0.029 33 30 $21,324,244
NOX NOXOPHARM LTD 0.23 31 -58 $40,051,256
IDT IDT AUSTRALIA LTD 0.19 28 0 $44,272,912
BOT BOTANIX PHARMACEUTICALS LTD 0.054 26 -52 $51,552,996
CAJ CAPITOL HEALTH LTD 0.225 25 -3 $230,084,368
ESE ESENSE-LAB LTD-CDI 0.01 25 -47 $1,900,769
BNO BIONOMICS LTD 0.0545 21 -58 $29,685,380
CAN CANN GROUP LTD 1.155 21 -45 $173,931,824
PYC PYC THERAPEUTICS LTD 0.088 21 267 $257,965,664
M7T MACH7 TECHNOLOGIES LTD 0.72 20 114 $127,117,216
PCK PAINCHEK LTD 0.18 19 42 $191,571,648
HLA HEALTHIA LTD 1.03 18 17 $64,925,692
FTT FACTOR THERAPEUTICS LTD 0.0035 17 -42 $3,649,925
GTG GENETIC TECHNOLOGIES LTD 0.006 17 7 $35,796,460
PAL PALLA PHARMA LTD 0.8 16 -28 $100,758,384
UBI UNIVERSAL BIOSENSORS INC-CDI 0.225 15 10 $39,928,360
THC THC GLOBAL GROUP LTD 0.385 15 -14 $53,492,424
S66 STAR COMBO PHARMA LTD 0.55 15 -28 $40,672,204
MMJ MMJ GROUP HOLDINGS LTD 0.13 13 -45 $29,894,018
RSH RESPIRI LTD 0.073 13 -51 $45,681,416
MDR MEDADVISOR LTD 0.59 12 47 $146,778,816
IHL IMPRESSION HEALTHCARE LTD 0.056 12 180 $40,847,292
PTX PRESCIENT THERAPEUTICS LTD 0.05 11 20 $19,318,770
ATH ALTERITY THERAPEUTICS LTD 0.018 11 -46 $20,747,160
IMU IMUGENE LTD 0.032 10 78 $141,631,056
OVN OVENTUS MEDICAL LTD 0.275 10 11 $41,123,536
MVP MEDICAL DEVELOPMENTS INTERNA 8.1 9 57 $541,393,792
VHT VOLPARA HEALTH TECHNOLOGIES 1.435 9 -19 $363,003,328
RHT RESONANCE HEALTH LTD 0.185 9 58 $84,317,048
RGS REGENEUS LTD 0.081 9 -26 $21,114,700
PNV POLYNOVO LTD 2.64 8 133 $1,784,937,728
PAB PATRYS LTD 0.013 8 -50 $13,943,674
LCT LIVING CELL TECHNOLOGIES LTD 0.013 8 -57 $7,428,733
DXB DIMERIX LTD 0.28 8 260 $49,012,212
ADR ADHERIUM LTD 0.027 8 -15 $13,917,236
MX1 MICRO-X LTD 0.145 7 -48 $51,789,336
SDX SIENNA CANCER DIAGNOSTICS LT 0.062 7 13 $24,498,236
CP1 CANNPAL ANIMAL THERAPEUTICS 0.093 7 -41 $8,753,750
ZLD ZELIRA THERAPEUTICS LTD 0.048 7 7 $46,681,364
IMM IMMUTEP LTD 0.18 7 -42 $78,020,952
PAR PARADIGM BIOPHARMACEUTICALS 2.58 6 78 $593,306,176
CTE CRYOSITE LTD 0.085 6 89 $3,983,063
NC6 NANOLLOSE LTD 0.035 6 -32 $3,701,250
BWX BWX LTD 3.79 6 139 $472,149,568
KZA KAZIA THERAPEUTICS LTD 0.415 5 -5 $39,258,324
ZNO ZOONO GROUP LTD 1.86 5 1069 $305,768,768
AMT ALLEGRA ORTHOPAEDICS LTD 0.115 5 15 $11,449,291
ADO ANTEOTECH LTD 0.023 5 57 $37,813,928
BD1 BARD1 LIFE SCIENCES LTD 0.028 4 36 $36,913,996
TD1 TALI DIGITAL LTD 0.031 3 72 $23,228,462
CYC CYCLOPHARM LTD 1.65 3 -2 $112,547,720
CGS COGSTATE LTD 0.32 3 35 $54,446,452
ONT 1300 SMILES LTD 5.31 3 -13 $125,732,216
OPT OPTHEA LTD 2.95 3 360 $804,781,760
PIQ PROTEOMICS INTERNATIONAL LAB 0.36 3 12 $33,536,520
PXS PHARMAXIS LTD 0.091 2 -68 $35,967,676
PBP PROBIOTEC LTD 1.965 2 25 $145,818,800
AVH AVITA MEDICAL LTD 0.455 1 2 $992,047,232
AVE AVECHO BIOTECHNOLOGY LTD 0.007 0 133 $11,182,202
ELX ELLEX MEDICAL LASERS LTD 0.5 0 -15 $71,800,568
IVX INVION LTD 0.009 0 -43 $44,004,852
BXN BIOXYNE LTD 0.014 0 -26 $8,962,036
CDX CARDIEX LTD 0.022 0 -28 $17,323,814
AC8 AUSCANN GROUP HOLDINGS LTD 0.17 0 -55 $53,898,052
ALT ANALYTICA LTD 0.003 0 -40 $10,558,837
BIT BIOTRON LTD 0.094 0 24 $65,279,744
APH AUSTRALIAN PRIMARY HEMP LTD 0.13 0 -41 $9,068,168
MEM MEMPHASYS LTD 0.068 0 164 $49,762,276
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.175 0 17 $13,717,302
ACR ACRUX LTD 0.135 0 -31 $22,752,700
GSS GENETIC SIGNATURES LTD 1.985 0 78 $279,517,568
MEB MEDIBIO LTD 0.007 0 -36 $6,965,911
NTI NEUROTECH INTERNATIONAL LTD 0.006 0 -45 $1,291,294
LSH LIFESPOT HEALTH LTD 0.033 0 -60 $2,630,920
VTI VISIONEERING TECH-CDI 0.016 0 -74 $7,452,829
FFC FARMAFORCE LTD 0.08 0 -30 $10,301,678
SDI SDI LTD 0.755 -1 -16 $89,743,472
ICS ICSGLOBAL LTD 1.85 -1 91 $19,140,254
MVF MONASH IVF GROUP LTD 0.565 -1 -45 $204,982,784
RHY RHYTHM BIOSCIENCES LTD 0.099 -1 -45 $9,369,750
IMC IMMURON LTD 0.084 -1 -56 $14,886,346
AGH ALTHEA GROUP HOLDINGS LTD 0.38 -1 -42 $89,824,352
RNO RHINOMED LTD 0.073 -1 -74 $12,267,436
UCM USCOM LTD 0.215 -2 30 $32,176,708
PSQ PACIFIC SMILES GROUP LTD 1.4 -2 18 $214,921,776
RAP RESAPP HEALTH LTD 0.17 -3 13 $124,970,312
HCT HOLISTA COLLTECH LTD 0.165 -3 150 $46,809,344
NYR NYRADA INC-CDI 0.155 -3 -22 $18,048,314
1ST 1ST GROUP LTD 0.029 -3 -40 $12,313,890
GLH GLOBAL HEALTH LTD 0.14 -3 7 $5,893,765
NEU NEUREN PHARMACEUTICALS LTD 1.675 -3 33 $173,325,632
MXC MGC PHARMACEUTICALS LTD 0.025 -4 -55 $39,390,308
TLX TELIX PHARMACEUTICALS LTD 1.355 -4 55 $357,638,944
CPH CRESO PHARMA LTD 0.068 -4 -85 $15,274,289
AHX APIAM ANIMAL HEALTH LTD 0.44 -4 3 $52,468,712
CYP CYNATA THERAPEUTICS LTD 0.69 -4 -44 $72,962,656
AZV AZURE HEALTHCARE LTD 0.067 -4 -15 $19,040,660
JHC JAPARA HEALTHCARE LTD 0.56 -4 -58 $148,322,272
VLS VITA LIFE SCIENCES LTD 0.57 -4 -20 $29,204,610
MDC MEDLAB CLINICAL LTD 0.21 -4 -46 $50,142,688
OIL OPTISCAN IMAGING LTD 0.043 -4 8 $20,544,488
OSX OSTEOPORE LTD 0.495 -5 148 $50,109,100
NXS NEXT SCIENCE LTD 1.55 -5 -44 $280,389,856
ALC ALCIDION GROUP LTD 0.16 -6 63 $148,604,112
SOM SOMNOMED LTD 1.09 -6 -32 $83,832,592
SKN SKIN ELEMENTS LTD 0.08 -7 82 $25,411,448
EXL ELIXINOL GLOBAL LTD 0.275 -8 -94 $50,276,272
RAC RACE ONCOLOGY LTD 0.33 -9 400 $36,989,588
OSL ONCOSIL MEDICAL LTD 0.105 -9 60 $82,293,168
SVA SIMAVITA LTD-CDI 0.02 -9 18 $11,275,563
CMP COMPUMEDICS LTD 0.51 -10 -13 $87,695,656
ACW ACTINOGEN MEDICAL LTD 0.018 -10 50 $20,092,164
ANR ANATARA LIFESCIENCES LTD 0.175 -10 -54 $8,724,831
ONE ONEVIEW HEALTHCARE PLC-CDI 0.047 -11 -81 $8,140,940
DVL DORSAVI LTD 0.023 -12 -63 $5,322,833
JHL JAYEX HEALTHCARE LTD 0.022 -12 -35 $3,879,987
GMV G MEDICAL INNOVATION HOLDING 0.069 -13 -71 $45,801,272
PAA PHARMAUST LTD 0.099 -13 146 $28,994,022
PGC PARAGON CARE LTD 0.17 -13 -61 $57,440,500
SUD SUDA PHARMACEUTICALS LTD 0.043 -14 -74 $6,116,939
OCC ORTHOCELL LTD 0.33 -14 -33 $60,950,580
SCU STEMCELL UNITED LTD 0.011 -15 -31 $7,057,692
CDY CELLMID LTD 0.185 -18 -5 $22,329,762
BPH BPH ENERGY LTD 0.008 -20 -20 $2,985,795

 

Body fluid monitor Impedimed (ASX:IPD) was the surprise flier this week after the stock more than doubled for no observable reason from May 20.

Over five days the stock shot up from 4c to 9c.

The company claimed innocence, saying “we have no explanation for the increase in share price and volume”.

But as often happens with ASX speeding tickets Impedimed did get a plug in for the business: “we do note that each of the analysts that cover the company, Canaccord Genuity, Wilsons HTM Equities Research and Morgans Financial, have recent price targets in excess of currently traded prices.”

Impedimed has been trying to make a living in the US for years, and may have finally cracked that nut according to Morgans Financial analyst Scott Power.

Amplia Therapeutics (ASX: ATX) received a second Orphan Drug Designation in the US for its idiopathic pulmonary fibrosis treatment.

The designation, for drugs seeking to treat rare diseases, means Amplia will qualify for waived US Food and Drug Administration fees, clinical trial protocol assistance and other incentives including around market exclusivity if the drug makes it that far.

‘Idiopathic’ refers to a condition which appears with no known cause. Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred.

Antisense Therapeutics (ASX:ANP) surged following final phase two clinical trial results for its immunomodulatory therapy, ATL1102 for Duchenne Muscular Dystrophy (DMD), that met primary and secondary endpoints.

The key outcome in the nine-boy trial was that it was safe and worked. The secondary outcomes met included functional capacity around grip and pinch strength. MRI assessments of upper limb muscles showed the drug appeared to stabilise the fat fraction percentage in the muscles of the forearm.

DMD is a debilitating disease that affects one in every 3500 to 5000 boys and causes muscles to deteriorate and breakdown.

Patients are wheelchair-bound by the time they reach eight to 11 years and many do not survive past their 20s.

Imagion (ASX:IBX) did a deal with Siemens to further develop protocols around putting its cancer-detecting nanoparticles into the body and the share price shot up.

Cancer biotech Noxopharm (ASX:NOX) fell just outside the top 10 movers but inside the top five that had any news to back a share price movement.

The company lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of its cancer treatment in patients with COVID-19.

It reckons it has an active ingredient in its drug, idronoxil, that inhibits an inflammatory pathway when the body goes into overdrive against COVID-19.

A pre-IND is an ‘introduction’ to the regulator, which can then decide whether to allow further studies go ahead.

IDT Australia (ASX:IDT) has finally seen some cannabis action.

Cann Group (ASX:CAN), for which it manufactures marijuana medications, said this week it signed and started two new export supply agreements with European and UK companies to supply medicinal cannabis formulated oil and dried flower products.

With cannabis and cannabis related stocks still wallowing in Australia (despite upward moves overseas), the news was a welcome change from the usual never-completed partnership MoU fluff common in the sector.